期刊文献+

胎儿真皮间充质干细胞中的全能性相关转录因子的表达 被引量:2

Detection of pluripotent transcription factors in fetal dermis-derived mesenchymal stem cells
下载PDF
导出
摘要 背景:人真皮纤维母细胞或间充质干细胞可形成诱导性多能干细胞,但不同研究者所用的转录因子组合却并不相同。目的:分离人胎儿真皮间充质干细胞,检测其全能性相关转录因子的表达。方法:水囊引产5月龄胎儿,按照既往分离培养间充质干细胞的方法,得到胎儿真皮间充质干细胞。结果与结论:胎儿真皮间充质干细胞高表达Oct4和C-myc、中度表达Sox2,是形成诱导性多能干细胞较好的体细胞。 BACKGROUND: The induced pluripotent stem (iPS) cells have been reprogrammed from human dermal fibroblasts and mesenchymal stem cells (MSCs). Various combinations of transcription factors are used by different investigators. OBJECTIVE: To detect the pluripotent transcription factors expressed in fetal dermis-derived MSCs. METHODS: Using previous methodology in isolation and cultivation of MSCs, fetal dermis-derived MSCs were obtained from 5-month-old fetus, inducing abortion by water bag. RESULTS AND CONCLUSION: Transcription factors of Oct4 and C-myc were expressed highly and Sox2 was expressed moderately. These results suggest that fetal dermis-derived MSCs are better somatic cells for iPS cells.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第32期5975-5978,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家973项目(2011CB964800),名称:造血干细胞维持、衰老与再生的调控机制研究 国家自然科学基金(30900557),名称:间充质干细胞对正常造血干细胞和白血病干细胞的作用 天津市应用基础与前沿技术研究计划项目(09JCYBJC11000),名称:抗内皮细胞噬菌体抗体在HSCT内皮损伤研究中的作用~~
  • 相关文献

参考文献7

二级参考文献36

  • 1郭虹,刘杰文,杨少光,曹德骏,刘津华,廖联明,赵春华.具有间充质干细胞特征的CD105^+细胞在胎儿多种组织器官的分布[J].细胞生物学杂志,2004,26(4):404-408. 被引量:2
  • 2霍思维,张毅.间充质干细胞在造血调控中的作用[J].中国实验血液学杂志,2006,14(1):187-190. 被引量:12
  • 3Huayu Qi,Duanqing Pei, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510663, China pei_duanqing@gibh.ac.cn.The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4[J].Cell Research,2007,17(7):578-580. 被引量:12
  • 4De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage ceils from human adipose tissue and bone marrow. Cells Tissues Organs, 2003; 174: 101- 109.
  • 5Campagnoli C, Roberts IA, Kumar S, et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood, 2001; 98:2396-2402.
  • 6Noort WA, Kruisselbrink AB, in't Anker PS, et al Mesenchymal stem ceils promote engraftment of human umbilical cord blood-derived CD34^+ ceils in NOD/SCID mice. Exp Hematol, 2002; 30: 870 - 878.
  • 7Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol, 2000; 109:235 -242.
  • 8Int Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isola- tion of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 2004 ; 22 : 1338 - 1345.
  • 9Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton'sjelly of the human umbilical cord. Stem Cells, 2004 ; 22 : 1330 - 1337.
  • 10Majumdar MK, Thiede MA, Haynesworth SE, et al. Human marrow-derived mesenchymal stem ceils (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated to- ward stromal and osteogenic lineages. J Hematother Stem Cell Res, 2000; 9:841 -848.

共引文献77

同被引文献50

  • 1邓洪新,田聆,魏于全.基因治疗的发展现状、问题和展望[J].生命科学,2005,17(3):196-199. 被引量:35
  • 2Robert C Zhao.Immunosuppressive properties of cloned bone marrow mesenchymal stem cells[J].Cell Research,2007,17(3):240-248. 被引量:32
  • 3Allen S J, Watson J J, Shoemark DK,et al.GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 2013; 138(2):155-175.
  • 4Colafrancesco V, Villoslada P.Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases.Arch Ital Biol. 2011;149(2): 183-192.
  • 5Saragovi HU, Gehring K.Development of pharmacological agents for targeting neurotrophins and their receptors.Trends Pharmacol Sci. 2000;21(3):93-98.
  • 6Kumar S, Chanda D, Ponnazhagan S.Therapeutic potential of genetically modified mesenchymal stem cells.Gene Ther. 2008; 15(10):711-715.
  • 7Gafni Y, Turgeman G, Liebergal M, et al.Stem cells as vehicles for orthopedic gene therapy.Gene Ther. 2004; 11(4): 417-426.
  • 8Fan BS, Lou JY.Recombinant expression of human nerve growth factor beta in rabbit bone marrow mesenchymal stem cells.Mol Biol Rep. 2010;37(8):4083-4090.
  • 9Rooney GE, Moran C, McMahon SS,et al.Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate.Tissue Eng Part A. 2008; 14(5):681-690.
  • 10Goins WF, Lee KA, Cavalcoli JD,et al.Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.J Virol. 1999;73(1):519-532.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部